Literature DB >> 8648377

Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.

R Corona1, A Mele, M Amini, G De Rosa, G Coppola, P Piccardi, M Fucci, P Pasquini, T Faraggiana.   

Abstract

PURPOSE: To assess the interobserver agreement on the diagnosis and classification of cutaneous melanoma.
MATERIALS AND METHODS: A set of 140 slides of cutaneous melanoma, including a small subset of benign pigmented skin lesions, were circulated to four experienced histopathologists. The kappa statistic for multiple ratings per subject was calculated using the method described by Fleiss.
RESULTS: The kappa value on the diagnosis of cutaneous melanoma versus benign lesions was 0.61. There was some discordance on the diagnosis in 37 of 140 cases (26%). For the histopathologic classification of cutaneous melanoma, the highest kappa values were attained for Breslow thickness (kappa = 0.76) and presence of ulceration (kappa = 0.87). The agreement was generally poor for other histologic features, such as level of dermal invasion (kappa = 0.38), presence of regression (kappa = 0.27), and lymphocytic infiltration (kappa = 0.27).
CONCLUSION: Our study suggests considerable disagreement among pathologists on the diagnosis of melanoma versus other pigmented lesions. Tumor thickness and presence of ulceration are the most reproducible histologic features of cutaneous melanoma.

Entities:  

Mesh:

Year:  1996        PMID: 8648377     DOI: 10.1200/JCO.1996.14.4.1218

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  38 in total

1.  Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.

Authors:  R D Ramirez; S D'Atri; E Pagani; T Faraggiana; P M Lacal; R S Taylor; J W Shay
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain.

Authors:  José Antonio Avilés-Izquierdo; Pablo Lázaro-Ochaita
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

3.  The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.

Authors:  Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan R Knezevich; Patricia A Carney; Lisa M Reisch; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2013-10-28       Impact factor: 11.527

4.  High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.

Authors:  Szu-Ying Chin; Pei-Ru Wu; Yi-Hsien Shih; Chung-Min Yeh; Woan-Ruoh Lee; Shing-Chuan Shen; Kun-Tu Yeh; Ming-Chung Jiang; Jonathan Te-Peng Tseng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Skin biopsy rates and incidence of melanoma: population based ecological study.

Authors:  H Gilbert Welch; Steven Woloshin; Lisa M Schwartz
Journal:  BMJ       Date:  2005-08-04

6.  Interobserver reproducibility of histological features in cutaneous malignant melanoma.

Authors:  C Urso; F Rongioletti; D Innocenzi; C Saieva; D Batolo; S Chimenti; R Filotico; R Gianotti; M Lentini; C Tomasini; A Rebora; M Pippione
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

7.  Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.

Authors:  Rajmohan Murali; Chris Goumas; Anne Kricker; Lynn From; Klaus J Busam; Colin B Begg; Terence Dwyer; Stephen B Gruber; Peter A Kanetsky; Irene Orlow; Stefano Rosso; Nancy E Thomas; Marianne Berwick; Richard A Scolyer; Bruce K Armstrong
Journal:  Ann Surg Oncol       Date:  2011-09-13       Impact factor: 5.344

8.  Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

Authors:  David E Elder; Michael W Piepkorn; Raymond L Barnhill; Gary M Longton; Heidi D Nelson; Stevan R Knezevich; Margaret S Pepe; Patricia A Carney; Linda J Titus; Tracy Onega; Anna N A Tosteson; Martin A Weinstock; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2018-03-07       Impact factor: 11.527

9.  Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.

Authors:  Jason P Lott; Joann G Elmore; Ge A Zhao; Stevan R Knezevich; Paul D Frederick; Lisa M Reisch; Emily Y Chu; Martin G Cook; Lyn M Duncan; Rosalie Elenitsas; Pedram Gerami; Gilles Landman; Lori Lowe; Jane L Messina; Martin C Mihm; Joost J van den Oord; Michael S Rabkin; Birgitta Schmidt; Christopher R Shea; Sook Jung Yun; George X Xu; Michael W Piepkorn; David E Elder; Raymond L Barnhill
Journal:  J Am Acad Dermatol       Date:  2016-05-14       Impact factor: 11.527

10.  [DNA copy number changes in the diagnosis of melanocytic tumors].

Authors:  J Bauer; B C Bastian
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.